• 15 Apr 26

Poolbeg hits significant milestone with POLB 001

Poolbeg hits significant milestone with POLB 001

Poolbeg Pharma PLC | POLB | 4.8 0.52 0.0%

    • 41 views

 
Poolbeg has announced some significant updates for the POLB 001 TOPICAL trial. This is a significant milestone for the company, for many reason, as chief executive Jeremy Skillington and principle scientist Liam Tremble explain

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Poolbeg Pharma, Arecor Therapeutics, hVIVO, Ilika, Kodal Minerals, Connecting Excellence

Companies: Poolbeg Pharma PLC

Poolbeg Pharma - AI Analysis of Human Challenge Data

Companies: Poolbeg Pharma PLC

Poolbeg Pharma: trial green-lit, billion-dollar market - and data due this summer

Companies: Poolbeg Pharma PLC

Poolbeg Pharma - Licence Signed for Development of Oral Vaccine Delivery Platform

Companies: Poolbeg Pharma PLC

Poolbeg Pharma CEO says POLB-001 patent win strengthens Big Pharma partnership potential

Companies: Poolbeg Pharma PLC

Poolbeg Pharma in MRC-backed cancer immunotherapy study

Companies: Poolbeg Pharma PLC

© Research Tree 2026

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top